InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by FISHER MARY, Director. Officer active across 3 companies, notably Sientra, Inc.. Cumulatively, 9 reports have been recorded. History available since 10 June 2021. The latest transaction was filed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
9 of 9 declarations
Mary Fisher is a Director at Sientra, Inc. and Dermata Therapeutics, Inc. In this role, she contributes to governance and strategic decision-making. Mary brings her expertise and advice to help guide the direction of the companies, ensuring they meet their objectives.